A dose-ranging study to evaluate the antiretroviral activity and safety of amprenavir alone and in combination with abacavir in HIV-infected adults with limited antiretroviral experience

RT Schooley, N Clumeck, R Haubrich, M Thompson, SA Danner, Marchina Ende, D Sereni, F Antunes, D Blake, RE Myers, M Tisdale, J Millard, N Mustafa, P Nacci

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)89-96
Number of pages8
JournalAntiviral Therapy
Publication statusPublished - 2001

Cite this